OBJECTIVE: We sought to relate circulating biomarkers of extracellular matrix turnover to site-specific measures of carotid artery atherosclerosis on duplex ultrasound. BACKGROUND: Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) regulate extracellular matrix remodeling, a key feature of atherosclerosis, and their circulating concentrations can be assayed. MMP-9, TIMP-1, and protocollagen-III n-terminal propeptide (PIIINP) may relate differentially to the severity of atherosclerosis at different carotid artery sites. However, data examining this premise are sparse. METHODS: We related circulating MMP-9, TIMP-1, and/or PIIINP concentrations to carotid atherosclerosis on duplex ultrasound in 1006 Framingham offspring (mean age 58 years, 56% women) who attended a routine examination from 1995 to 1998. We used multivariable regression to relate MMP-9 (detectable v undetectable), TIMP-1, and PIIINP (age- and sex-specific quartiles) to internal carotid artery (IC) stenosis (>25%) and log-transformed common carotid artery and IC intima-media thickness (IMT). RESULTS: Detectable MMP-9 was associated with carotid stenosis (odds ratio [OR] 1.71, P = .032) but not with IMT. Higher TIMP-1 was associated with carotid stenosis (OR for Quartiles (Q)4 v Q1-3, 1.63, P = .022) and a higher IC IMT (beta 0.057 +/- 0.025, Q4 v Q1-3, P = .023). Higher PIIINP (Q4 v Q1-3) showed a borderline association with carotid stenosis (OR 1.45 for Q4 v Q1-3, P = .095) but not with IMT. TIMP-1 was not associated with common carotid artery IMT. CONCLUSIONS: In our community-based sample of middle-aged to older adults, higher circulating biomarkers of matrix remodeling were associated with a greater prevalence of carotid stenosis and subclinical atherosclerosis in the IC. Our findings are consistent with regional differences in matrix remodeling in the carotid artery.
OBJECTIVE: We sought to relate circulating biomarkers of extracellular matrix turnover to site-specific measures of carotid artery atherosclerosis on duplex ultrasound. BACKGROUND: Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) regulate extracellular matrix remodeling, a key feature of atherosclerosis, and their circulating concentrations can be assayed. MMP-9, TIMP-1, and protocollagen-III n-terminal propeptide (PIIINP) may relate differentially to the severity of atherosclerosis at different carotid artery sites. However, data examining this premise are sparse. METHODS: We related circulating MMP-9, TIMP-1, and/or PIIINP concentrations to carotid atherosclerosis on duplex ultrasound in 1006 Framingham offspring (mean age 58 years, 56% women) who attended a routine examination from 1995 to 1998. We used multivariable regression to relate MMP-9 (detectable v undetectable), TIMP-1, and PIIINP (age- and sex-specific quartiles) to internal carotid artery (IC) stenosis (>25%) and log-transformed common carotid artery and IC intima-media thickness (IMT). RESULTS: Detectable MMP-9 was associated with carotid stenosis (odds ratio [OR] 1.71, P = .032) but not with IMT. Higher TIMP-1 was associated with carotid stenosis (OR for Quartiles (Q)4 v Q1-3, 1.63, P = .022) and a higher IC IMT (beta 0.057 +/- 0.025, Q4 v Q1-3, P = .023). Higher PIIINP (Q4 v Q1-3) showed a borderline association with carotid stenosis (OR 1.45 for Q4 v Q1-3, P = .095) but not with IMT. TIMP-1 was not associated with common carotid artery IMT. CONCLUSIONS: In our community-based sample of middle-aged to older adults, higher circulating biomarkers of matrix remodeling were associated with a greater prevalence of carotid stenosis and subclinical atherosclerosis in the IC. Our findings are consistent with regional differences in matrix remodeling in the carotid artery.
Authors: Andrew D Mackinnon; Paula Jerrard-Dunne; Matthias Sitzer; Alexandra Buehler; Stefan von Kegler; Hugh S Markus Journal: Stroke Date: 2004-07-08 Impact factor: 7.914
Authors: Lynne E Wagenknecht; Daniel Zaccaro; Mark A Espeland; Andrew J Karter; Daniel H O'Leary; Steven M Haffner Journal: Arterioscler Thromb Vasc Biol Date: 2003-04-17 Impact factor: 8.311
Authors: Johan Sundström; Jane C Evans; Emelia J Benjamin; Daniel Levy; Martin G Larson; Douglas B Sawyer; Deborah A Siwik; Wilson S Colucci; Peter W F Wilson; Ramachandran S Vasan Journal: Eur Heart J Date: 2004-09 Impact factor: 29.983
Authors: Johan Sundström; Jane C Evans; Emelia J Benjamin; Daniel Levy; Martin G Larson; Douglas B Sawyer; Deborah A Siwik; Wilson S Colucci; Patrice Sutherland; Peter W F Wilson; Ramachandran S Vasan Journal: Circulation Date: 2004-06-01 Impact factor: 29.690
Authors: Isha Agarwal; Alice Arnold; Nicole L Glazer; Eddy Barasch; Luc Djousse; Annette L Fitzpatrick; John S Gottdiener; Joachim H Ix; Richard A Jensen; Jorge R Kizer; Eric B Rimm; David S Siscovick; Russell P Tracy; Tien Y Wong; Kenneth J Mukamal Journal: Atherosclerosis Date: 2015-02-16 Impact factor: 5.162
Authors: Raghava S Velagaleti; Philimon Gona; Johan Sundström; Martin G Larson; Deborah Siwik; Wilson S Colucci; Emelia J Benjamin; Ramachandran S Vasan Journal: Arterioscler Thromb Vasc Biol Date: 2010-08-26 Impact factor: 8.311
Authors: Táňa Fadrná; Zdeňka Mikšová; Roman Herzig; Kateřina Langová; Libor Ličman; David Školoudík Journal: Health Qual Life Outcomes Date: 2018-04-27 Impact factor: 3.186